AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Maxygen to Present at the Cowen & Co. 26th Annual Health Care Conference and the Lehman Brothers Ninth Annual Global Healthcare Conference.
REDWOOD CITY, Calif., March 1 /PRNewswire-FirstCall/ -- Maxygen, Inc. today announced that Russell Howard, Ph.D., Maxygen's chief executive officer, will present a corporate overview at the Cowen & Co. Health Care Conference on Tuesday, March 7th at 4:00 p.m. ET at the Boston Marriott Copley Place and at the Lehman Brothers Ninth Annual Healthcare Conference on Wednesday, March 8th at 4:15 p.m. at the Loews Miami Beach Hotel. Both presentations will be webcast and can be accessed by visiting the investor relations section of Maxygen's website at http://www.maxygen.com/.
The presentations will include discussion of non-GAAP financial measures. Reconciliation of the ...
- Maxygen, Inc. Announces Webcast of Corporate Presentation at the Lehman...
- Press release article from: PR Newswire March 28, 2005 700+ words
...PRNewswire-FirstCall/ -- Maxygen, Inc. announced today that the company will present at the Lehman Brothers Eighth Annual Global Healthcare...website at http://www.maxygen.com/. The webcast will...following the presentation. Maxygen, Inc., headquartered in...
- Maxygen Announces New Development Program and Product Development...
- Press release article from: PR Newswire December 4, 2004 700+ words
Maxygen, Inc. announced today that it will advance...development of its interferon beta program. Maxygen has generated a novel factor VIIa (MAXY...blood loss in relevant preclinical models. Maxygen believes its MAXY-VII product candidate...
- Maxygen and Rentschler Sign Agreement to Manufacture Novel G-CSF.
- Press release article from: PR Newswire September 9, 2004 700+ words
Maxygen, Inc. and Rentschler Biotechnologie GmbH...Phase I and Phase II clinical supplies of Maxygen's next-generation granulocyte cell stimulating factor (G-CSF) molecule. Maxygen has developed a next-generation G-CSF...
- MAXYGEN SIGNS INTERFERON DEAL WITH ROCHE WORTH UP TO $230M.(F. Hoffmann-La...
- Magazine article from: BIOWORLD Today Huggett, Brady May 23, 2003 700+ words
...Huggett , Associate Managing Editor Maxygen Inc. signed a deal with F. Hoffmann-La Roche Ltd. focused on Maxygen's interferon alpha and beta variants...more than $230 million. Simba Gill, Maxygen's president, said the deal came to...
- Maxygen Reports First Quarter 2006 Financial Results.
- Press release article from: PR Newswire April 25, 2006 700+ words
...April 25 /PRNewswire-FirstCall/ -- Maxygen, Inc. today reported financial results...first quarter ended March 31, 2006. Maxygen reported a loss applicable to common stockholders...For the quarter ended March 31, 2006, Maxygen reported a loss from continuing operations...
- Maxygen and H. Lundbeck A/S Enter Into Research and Development Agreement.
- Press release article from: PR Newswire September 19, 2000 700+ words
...CITY, Calif., Sept. 19 /PRNewswire/ -- Maxygen ApS, a wholly owned subsidiary of Maxygen, Inc. (Nasdaq: MAXY) and H. Lundbeck...product for central nervous system diseases. Maxygen has retained rights for neurological indications...
- Maxygen Reports Third Quarter 2006 Financial Results.
- Press release article from: PR Newswire October 30, 2006 700+ words
...Oct. 30 /PRNewswire-FirstCall/ -- Maxygen, Inc. today reported financial results...an update on the company's business. Maxygen reported a loss applicable to common stockholders...revenues is primarily attributable to Maxygen's ongoing collaboration with Roche for...
- Maxygen and Biovitrum Sign Agreement to Manufacture Optimized Beta Interferon...
- Press release article from: PR Newswire June 8, 2004 700+ words
Maxygen, Inc. and Biovitrum AB today announced...of an agreement for the manufacture of Maxygen's improved interferon beta material for...Vice President Business Development of Maxygen. "The manufacturing of our improved interferon...